
- Start date
- Duration
- Format
- Language
- 11 Jun 2025
- 9 days
- Class
- Italian
Last summer, Decree 9 of August 2019 was published in the Official Gazette, which revised the system for regulating drug pricing in Italy (Price Decree). The Italian Drug Agency (AIFA) held a public consultation, which wrapped up in September, to discuss guidelines consequent to the new legislative initiative during which drug companies submitted documentation to substantiate requests on eligibility for reimbursement and prices of their products. CERGAS (the Italian Research Center for Healthcare Management) at SDA Bocconi School of Management participated in this public consultation with a document in which, in addition to offering certain technical observations, underscored the importance of making decisions based on a structured and reproducible assessment of the value of new pharmaceuticals.
READ MORE ON SDA BOCCONI INSIGHT>>
Approfondire il contesto in cui operano gli attori del sistema salute, le principali tecniche per veicolare il valore di un farmaco e per una negoziazione sostenibile.
Acquisire conoscenze e strumenti riguardanti la regolamentazione, organizzazione, implementazione e valutazione delle innovazioni tecnologiche nel settore sanitario.